+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years - 55Years
FEMALE
Healthy Volunteers
ID07195071

Evaluating Combined Obstetrical Carrier and Hereditary Cancer Screening During Prenatal Care at Columbia University

Led by Columbia University · Updated on 2026-10-21

1000

Participants Needed

1

Research Sites

52 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are exploring whether offering hereditary cancer risk screening alongside routine prenatal or preconception care is practical and acceptable. This observational study aims to assess patient interest in genetic cancer testing during obstetrical care and to evaluate if universal screening at this time could support early cancer prevention. The study is conducted at Columbia University-affiliated OBGYN clinics and focuses on patients receiving obstetrical carrier screening OCS. Participants will be offered a choice to add hereditary cancer screening HCS using the Natera Empower Comprehensive Hereditary Cancer Panel at the time of their standard OCS blood draw. Counseling on personal and family cancer risk will be provided, including potential costs and options for additional genetic counseling or financial consultation. OCS and HCS results are reported separately with genetic counseling support available. Participants who test positive for mutations with clinical follow-up recommendations will be contacted 18 months later to assess if they completed recommended medical follow-up. Throughout the study, participants will be asked to complete surveys on acceptance of the combined testing and their feelings about healthcare decisions. Participation in surveys and interviews is encouraged but optional. All data, including demographics, survey responses, and test results, are securely stored by the Columbia University OBGYN department. The primary measure is the percentage of participants completing both HCS and OCS, with follow-up outcomes assessed up to 18 months after enrollment. The study runs from February 2026 through December 2028.

CONDITIONS

Brief Title

Feasibility Trial of Combination of Obstetrical Carrier Screening and Hereditary Cancer Screening

Research Team

J

Jessica Giordano

R

Reena Vattakalam

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here